We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...
Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and increased the price target ...
For our list of the worst Ark stocks to buy according to short sellers, we ranked the 110 largest holdings in Ark Invest’s Q3 ...
Analyst Gil Blum from Needham reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and keeping the price target at ...
"Moving to the OTCQX Market marks an important step forward for the Group,” said Tom Griffith, CEO. "It opens the door to a ...
Massachusetts Financial Services Co. MA lowered its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 29.3% ...
In a remarkable display of market performance, Nurix Therapeutics Inc. stock has reached a 52-week high, touching $27.61. This milestone underscores a period of ...
“PRIME designation for NX-5948 is an important recognition of the unmet patient need in CLL, particularly in the growing number of patients whose cancer has progressed following BTK inhibitor and BCL2 ...
The session started a little shaky, but stocks quickly shifted into rally-mode as investors digested NVIDIA's (NVDA 146.67, +0.78, +0.5%) Q3 earnings report. Shares of NVDA initially traded lower due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback